Vitamin C for kidney injury in liver failure with septic shock
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests whether high-dose vitamin C can help protect the kidneys in people with severe liver disease, kidney injury, and a life-threatening infection. If you or your loved one is in the ICU with these conditions, this study may offer a treatment that could improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a sudden worsening of a chronic liver condition (ACLF) and a kidney injury caused by a severe infection that requires blood pressure support (septic shock).
- You are 18 years or older.
- You do not have any active bleeding or very high bleeding risk.
- You are not allergic to vitamin C and do not have conditions like G6PD deficiency, kidney stones, or chronic kidney disease.
- You are not pregnant or breastfeeding.
- You are not already on dialysis or have a history of kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
This Phase 2 study tests whether early high-dose vitamin C given through a vein can improve outcomes for people who remain unconscious after an out-of-hospital cardiac arrest with shock. It may help by supporting recovery during the time when the body is under severe stress.
This trial tests whether high-dose vitamin C given through an IV can improve outcomes in people with severe pneumonia. It may help your body fight infection and reduce complications, but it also has several safety checks.
This trial tests if adding an iron chelator (MEX-CD1) to the dialysis fluid can help remove harmful iron from the blood in patients with sepsis-related acute kidney injury who need continuous dialysis. It may reduce damage to the kidneys and other organs.
This trial tests whether a combination of vitamins B6, B12, and C can help improve blood flow in tiny blood vessels (microcirculation) for people with sepsis. It may help your body recover better from severe infection.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
Hear when a new Acute-on-Chronic Liver Failure (ACLF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.